Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Harpreet Singh, PhD$1B
Market Cap • 24/04/20242020
(há 4 anos)
2020
(4 years ago)
NASDAQ
Listagem
Tubingen
Sede • BW442
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IMTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.